Chemoinformaics analysis of 2,4-Imidazolidinedione
| Molecular Weight | 100.077 | nRot | 0 |
| Heavy Atom Molecular Weight | 96.045 | nRig | 6 |
| Exact Molecular Weight | 100.027 | nRing | 1 |
| Solubility: LogS | -1.166 | nHRing | 1 |
| Solubility: LogP | -0.892 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 11 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 4 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 3 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 11.4812 |
| nHD | 2 | BPOL | 6.88883 |
| QED | 0.407 |
| Synth | 3.482 |
| Natural Product Likeliness | -0.025 |
| NR-PPAR-gamma | 0.001 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.004 |
| HIA | 0.904 |
| CACO-2 | -5.411 |
| MDCK | 0.0000159 |
| BBB | 0.114 |
| PPB | 0.0704899 |
| VDSS | 0.611 |
| FU | 0.8735 |
| CYP1A2-inh | 0.014 |
| CYP1A2-sub | 0.971 |
| CYP2c19-inh | 0.033 |
| CYP2c19-sub | 0.053 |
| CYP2c9-inh | 0.01 |
| CYP2c9-sub | 0.229 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.052 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.127 |
| CL | 9.889 |
| T12 | 0.929 |
| hERG | 0.021 |
| Ames | 0.025 |
| ROA | 0.184 |
| SkinSen | 0.177 |
| Carcinogencity | 0.269 |
| EI | 0.905 |
| Respiratory | 0.083 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.973667 |